Evaxion Biotech Stock Forward View - Simple Moving Average
| EVAX Stock | USD 3.58 0.50 16.23% |
The successful prediction of Evaxion Biotech's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Evaxion Biotech AS, which may create opportunities for some arbitrage if properly timed.
As of today, the 14-period RSI for Evaxion Biotech stands at 44, indicating moderately negative momentum. This range suggests moderated price movement without extreme directional pressure.Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.01 | EPS Estimate Next Year 0.11 | Wall Street Target Price 11.25 | Quarterly Revenue Growth -1.00 |
This view frames how Evaxion Biotech AS responds to recent headlines and peer activity within its market context.
Evaxion Relative Strength Index
The Simple Moving Average forecasted value of Evaxion Biotech AS on the next trading day is expected to be 3.58 with a mean absolute deviation of 0.19 and the sum of the absolute errors of 11.59.Evaxion Biotech AS Hype to Price Pattern
Investor biases related to Evaxion Biotech's public news can be used to forecast risks associated with an investment in Evaxion. The trend in average sentiment can be used to explain how an investor holding Evaxion can time the market purely based on public headlines and social.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Evaxion Biotech's market sentiment to its price can help traders make decisions based on the overall investor consensus about Evaxion Biotech.
The Simple Moving Average forecasted value of Evaxion Biotech AS on the next trading day is expected to be 3.58 with a mean absolute deviation of 0.19 and the sum of the absolute errors of 11.59.Evaxion Biotech after-hype prediction price | $ 3.58 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use Historical Fundamental Analysis of Evaxion Biotech to cross-verify projections for Evaxion Biotech. The view provides historical context for the projection set.Evaxion Biotech Additional Predictive Modules
Most predictive techniques to examine Evaxion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evaxion using various technical indicators. When you analyze Evaxion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Evaxion Biotech Simple Moving Average Price Forecast For the 12th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Evaxion Biotech AS on the next trading day is expected to be 3.58 with a mean absolute deviation of 0.19 , mean absolute percentage error of 0.07 , and the sum of the absolute errors of 11.59 .Please note that although there have been many attempts to predict Evaxion Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Evaxion Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Evaxion Biotech Stock Forecast Pattern
| Backtest Evaxion Biotech | Evaxion Biotech Price Prediction | Research Analysis |
Evaxion Biotech Forecasted Value
This next-day forecast for Evaxion Biotech AS uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Evaxion Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Evaxion Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.5922 |
| Bias | Arithmetic mean of the errors | 0.0711 |
| MAD | Mean absolute deviation | 0.1932 |
| MAPE | Mean absolute percentage error | 0.0479 |
| SAE | Sum of the absolute errors | 11.595 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Evaxion Biotech's price to converge to an average value over time is called mean reversion.
Evaxion Biotech After-Hype Price Density Analysis
As far as predicting the price of Evaxion Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Evaxion Biotech Estimiated After-Hype Price Volatility
In the context of predicting Evaxion Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evaxion Biotech's historical news coverage.
Current Value
The after-hype framework applied to Evaxion Biotech AS assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Evaxion Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Evaxion Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evaxion Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evaxion Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.80 | 5.93 | 0.14 | 0.75 | 7 Events | 2 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.58 | 3.58 | 0.00 |
|
Evaxion Biotech Hype Timeline
Evaxion Biotech AS is currently traded for 3.58. The company has historical hype elasticity of -0.14, and average elasticity to hype of competition of -0.75. Evaxion is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.8%. %. The volatility of related hype on Evaxion Biotech is about 635.07%, with the expected price after the next announcement by competition of 2.83. About 17.0% of the company shares are held by company insiders. The company recorded a loss per share of 4.0. Evaxion Biotech AS had not issued any dividends in recent years. The company completed a 1:5 stock split on 14th of January 2025. Given the investment horizon of 90 days the next forecasted press release will be in 7 days. Use Historical Fundamental Analysis of Evaxion Biotech to cross-verify projections for Evaxion Biotech. The view provides historical context for the projection set.Evaxion Biotech Related Hype Analysis
Having access to credible news sources related to Evaxion Biotech's direct competition is more important than ever and may enhance your ability to predict Evaxion Biotech's future price movements. Getting to know how Evaxion Biotech's peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| WAMFX | Walden Midcap Fund | -0.89 | 4 per month | 0.55 | 0.09 | 1.35 | -1.03 | 8.33 | |
| ASYS | Amtech Systems | -0.54 | 9 per month | 6.54 | 0.13 | 7.59 | -6.85 | 47.60 | |
| SRAD | Sportradar Group AG | 0.04 | 12 per month | 0.00 | -0.11 | 3.38 | -4.19 | 16.98 | |
| MRSK | Northern Lights | 0.93 | 2 per month | 0.83 | 0.01 | 1.10 | -1.37 | 3.63 | |
| AMYZF | American Manganese | 0.00 | 0 per month | 0.00 | -0.13 | 11.25 | -11.70 | 34.02 | |
| SITKF | Sitka Gold Corp | 0.00 | 0 per month | 2.82 | 0.06 | 7.81 | -5.71 | 17.28 | |
| GJUN | First Trust Exchange Traded | -0.01 | 2 per month | 0.20 | 0.07 | 0.38 | -0.33 | 1.28 | |
| IDCC | InterDigital | -7.00 | 7 per month | 2.47 | 0.05 | 5.09 | -3.67 | 16.69 |
Other Forecasting Options for Evaxion Biotech
For every potential investor in Evaxion, whether a beginner or expert, Evaxion Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.Evaxion Biotech Related Equities
The following equities are related to Evaxion Biotech within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Evaxion Biotech against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Evaxion Biotech Market Strength Events
Market strength indicators help investors to evaluate how Evaxion Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evaxion Biotech shares will generate the highest return on.
Evaxion Biotech Risk Indicators
The analysis of Evaxion Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Evaxion Biotech's investment and either accepting that risk or mitigating it.
| Mean Deviation | 4.64 | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Evaxion Biotech
Coverage intensity for Evaxion Biotech AS matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Evaxion Biotech Short Properties
Short sentiment tied to Evaxion Biotech AS matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 6.4 M | |
| Cash And Short Term Investments | 23.2 M |
More Resources for Evaxion Stock Analysis
A structured review of Evaxion Biotech AS often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Evaxion Biotech AS Stock. Outlined below are key reports that provide context for Evaxion Biotech AS Stock:Use Historical Fundamental Analysis of Evaxion Biotech to cross-verify projections for Evaxion Biotech. The view provides historical context for the projection set. Analysis related to Evaxion Biotech should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Earnings Share -4.00 | Revenue Per Share | Quarterly Revenue Growth -1.00 | Return On Assets | Return On Equity |
The market value of Evaxion Biotech AS is measured differently than book value, which reflects Evaxion accounting equity. Evaxion Biotech's market capitalization is 29.86 M. With a P/B ratio of 8.51, the market values Evaxion Biotech well above its book equity. Enterprise value stands at 26.1 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Evaxion Biotech's intrinsic value and market price are different measures derived from different inputs. For Evaxion Biotech, key inputs include a P/B ratio of 8.51, a profit margin of -102.38%, ROE of -100.18%, and revenue of 7.55 M. By contrast, market price reflects the level where buyers and sellers transact.